ABx Group Limited Overview
ABx Group is a Melbourne-headquartered, ASX-listed micro-cap. It has repositioned from a bauxite explorer-miner into a three-pillar critical-materials developer, with every asset in Australia.
Its lead asset is the Deep Leads ionic-adsorption-clay rare earth province in northern Tasmania. The JORC resource is 89 Mt. The company states its dysprosium-plus-terbium share of total rare earth oxides (4.3%) is the highest of any Australian clay-hosted deposit. A maiden mixed rare earth carbonate (MREC) has been produced and sampled by customers.
The second pillar is the 83%-owned ALCORE. It is commercialising a proprietary process that recovers hydrogen fluoride from surplus aluminium smelter "bath", with a continuous pilot plant under construction beside Rio Tinto's Bell Bay smelter.
The third pillar is a bauxite portfolio across Queensland, New South Wales and Tasmania. It is being monetised through a partnership with Good Importing International.
The company is pre-revenue (FY2025 mineral sales of A$115k) and funds itself through serial equity placements, grants and R&D tax offsets. Its auditor's report carries a material going-concern uncertainty.
Company's own description (paraphrased from AR FY2025, Review of Operations)
ABx describes itself as a uniquely positioned Australian company delivering materials "for a cleaner future." It names three current areas of focus:
-
Heavy rare earths: supplying light and heavy rare earths from Tasmania into Western supply chains.
-
Clean fluorine chemical production: producing industrial chemicals from an aluminium smelter by-product, through ALCORE.
-
Near-term bauxite production: mining bauxite for the aluminium, cement and fertiliser industries.
The company also states that it follows best practice on agricultural land, aims to leave land better than it finds it, and only operates where it is welcomed.
Formally, the principal activities in FY2025 were rare earths and bauxite exploration in Queensland, NSW and Tasmania, plus R&D programs in NSW and Tasmania (AR FY2025, Directors' Report).
Independent characterisation
| Pillar | Stage (Oct 2026) | Economic model once operating | Value-chain position |
|---|---|---|---|
| Deep Leads rare earths (Tas) | Resource defined (89 Mt); maiden and second MREC produced at lab/bulk-sample scale with ANSTO; process-options studies done; scoping/economic studies in progress | Sale of MREC intermediate to rare earth separation plants (e.g., Ucore, Rare Earth Technologies) under offtake | Upstream: mining plus heap/tank leach plus precipitation to MREC; no separation or magnet making |
| ALCORE fluorine chemicals (Tas) | Batch pilot proven; continuous pilot plant under construction at Bell Bay; installation early Q4 2026 to Q1 2027 | Takes smelter "bath" (about 50% fluorine) from aluminium smelters; sells anhydrous HF and, downstream, aluminium fluoride (AlF3) plus metal sulfate co-products | Midstream chemical processing; circular-economy recycling of an industrial by-product |
| Bauxite (Qld, NSW, Tas) | Sunrise: approvals underway, funded by partner GII. DL130: mining lease granted, planning appeal in mediation. Taralga/Penrose: 100% ABx, GII option lapsed Aug 2026 | Direct-shipping-ore (DSO) bauxite sales for alumina refining (metallurgical grade), cement and fertiliser | Upstream mining and haulage; port export (Bundaberg, Port Kembla) or domestic cement supply |
ABx is best understood as a portfolio of three option-value development projects inside one listed shell. None of the three is yet producing.
Revenue model mix (FY2025 actual):
-
Product revenue (mineral sales): A$115k.
-
Non-operating income: A$1,873k, made up of R&D tax incentive A$824k, MMI grant income A$987k, other grants A$7k and interest A$55k.
-
Service, subscription and licensing revenue: none.
Prospectively, ALCORE could license its process to third-party smelters, but no licensing model has been publicly disclosed.
Customer types and end-markets (prospective):
-
Rare earth separation refiners outside China, serving permanent-magnet makers for EVs, wind turbines, robotics, electronics and defence.
-
Aluminium smelters as buyers of AlF3 and suppliers of bath feedstock.
-
HF consumers: fluorocarbons and refrigerants, fluoropolymers, semiconductors, solar cells and lithium-ion battery materials.
-
Alumina refineries, cement producers (e.g., Adelaide Brighton Cement's Birkenhead plant) and fertiliser producers for bauxite.
Strategy
Stated strategy themes (AR FY2025; AGM 26 May 2026)
| Lever | Rare earths (Deep Leads) | ALCORE |
|---|---|---|
| 1 | Resource growth: explore the expanding northern-Tasmania tenement holding | Pilot plant: build and run the continuous pilot to validate commercial design parameters |
| 2 | Project design: economic studies supported by metallurgy (in-house, ANSTO, engineering partners) | Project design: economic studies with international engineering partners |
| 3 | Customer engagement: Ucore Rare Metals, Rare Earth Technologies and others | Customer engagement: Australian and international customers |
ABx frames itself as delivering materials for a cleaner future through three priority projects. For both rare earths and ALCORE, management names the same three levers to reach commercial production "as soon as possible":
For bauxite, the stated strategy is to selectively produce metallurgical-, cement- and fertiliser-grade bauxite with a focus on profitability. It is executed through partner capital (GII) rather than ABx balance-sheet capital.
Initiative register (last 24 months)
| Date | Initiative | Detail / target |
|---|---|---|
| Sep 2024 | Ucore MOU | Framework for Ucore to buy and potentially invest in the Tasmanian rare earths project |
| 15 Jan 2025 | Bell Bay ATC lease | Leased from Rio Tinto at a reduced rate; supported by the Tasmanian Government |
| 9 Apr 2025 | Pilot equipment ordered | Oleum plant, bath reactors, scrubbers, cooling tower |
| 2 May 2025 | Resource upgrade to 89 Mt | Deep Leads–Rubble Mound plus Wind Break |
| Sep 2025 | Overseas R&D Finding | AusIndustry approval covering 2024–2026 offshore R&D with BFluor Chemicals (South Africa) and international suppliers, including more than A$2M of pilot capex |
| 12 Sep 2025 | GII bauxite partnership | Up to A$5.4M for 75% of ABX3 (Sunrise); option at A$4.8M for 75% of ABX2 (lapsed Aug 2026) |
| Late 2025 | Industry Growth Program application | ALCORE Commercialisation and Growth Grant. The AR states A$3.03M; Sep 2026 coverage cites "up to A$5M". In merit assessment; outcome expected before end-2026 |
| 2 Dec 2025 | Maiden MREC | 4.0% Dy, 0.7% Tb of TREO |
| 11 Mar 2026 | CMCI CRC partnership | Partner in the Critical Metals for Critical Industries Cooperative Research Centre (A$53M federal funding) |
| 11 Mar 2026 | TeraGlo quantum sensor | A$2.4M Critical Technologies Challenge Program grant (with TeraGlo) for a quantum-enabled geometallurgy sensor for clay-hosted rare earths |
| 27 Mar 2026 | ALCORE Environmental Effects Report | Submitted to EPA Tasmania |
| 2 Jul 2026 | ALCORE cost positioning | Opex US$1,000–1,600/t HF; 30–60% operating margin vs fluorspar route |
| 13 Jul 2026 | Pilot construction accelerating | Major civil and electrical works; staged installation early Q4 2026 to Q1 2027, then cold commissioning |
| Sep 2026 | Deep Leads infill drilling | Targeting optimum mining zones within the 89 Mt resource |
Medium-term targets and guidance
| Item | Guidance as at Nov 2025 | Mar 2026 | Jul 2026 |
|---|---|---|---|
| ALCORE pilot equipment delivery | Q1 2026 | First delivery Apr 2026 | Ongoing |
| ALCORE commissioning | Q2 2026 (operations Q3 2026) | Late Q3 2026 | Installation early Q4 2026–Q1 2027; cold commissioning after |
| Sunrise Stage 1 completion | 12–24 months from Oct 2025 | 2,027 | 2027 (approvals-dependent) |
No financial guidance is given (no revenue, EBITDA or capex targets). Operational timing guidance has slipped repeatedly:
ESG commitments. No quantified emissions targets are disclosed. Sustainability claims are qualitative:
-
ALCORE's circular economy (recycling smelter waste and displacing imports).
-
Low-radioactivity rare earths (2 ppm U, 6 ppm Th).
-
Ambient-temperature leaching.
-
Proximity to grid hydropower.
Products & Services
ABx has no commercial product line yet. Its "portfolio" consists of development products and the projects that will supply them.
Rare earths pillar
| Item | Description | Key specifications | Target customer | Status / year | Pricing |
|---|---|---|---|---|---|
| Maiden MREC | Mixed rare earth carbonate from Deep Leads ore, via leaching, impurity removal and precipitation (in-house and at ANSTO) | 4.0% Dy and 0.7% Tb as % of TREO; company says this is more than twice any peer MREC. Specific radioactivity met IAEA exemption criteria (ASX 2 Mar 2026) | Rare earth separation refiners outside China | Produced 2025 (ASX 2 Dec 2025); samples sent to multiple prospective customers; first formal feedback "highly favourable" (ASX 20 Mar 2026) | Not disclosed. Benchmark (Nov 2025, cited in AR) puts Dy oxide above US$200/kg and Tb oxide above US$900/kg DDP China; CIF Europe more than 3x Chinese domestic |
| Second MREC (column-leach liquor) | MREC from ANSTO column leach tests on a 100 kg bulk sample, simulating heap leach | Higher heavy rare earth proportion and fewer key impurities than the maiden MREC | Same | ASX 16 Mar 2026 | — |
| Deep Leads–Rubble Mound / Wind Break resource | Ionic-adsorption-clay rare earth deposits | 89 Mt JORC; 36 ppm Dy+Tb (Dy2O3+Tb4O7); Dy+Tb = 4.3% of TREO; 2 ppm U3O8 and 6 ppm ThO2. AR footnote classifies it as inferred, indicated and measured (exact split partly garbled in the extracted text) | Feed for MREC plant | Resource dated 2 May 2025; infill drilling to identify optimum mining zones (Sep 2026) | Not applicable |
| T8 and T30 discoveries | New rare earth discoveries in EL27/2022 (Temple Bar) and EL28/2022 (Triangle Flats), southeast of Launceston | Many intercepts above 350 ppm TREO-CeO2 cut-off | Resource growth | ASX 20 Jan 2026 | Not applicable |
| Flowsheet options | Tank leach (ammonium sulfate slurry) versus heap leach | Column tests: above 80% TREO and above 70% Dy/Tb extraction at ambient temperature and pressure | Project design | ASX 23 Jan 2026 | Not applicable |
ALCORE fluorine chemicals pillar
| Item | Description | Key specifications | Target customer | Status | Pricing / cost |
|---|---|---|---|---|---|
| Anhydrous hydrogen fluoride (AHF) | Recovered from aluminium smelter bath (about 50% F) using a proprietary sulfuric acid/oleum process | Batch pilot achieved 97% fluorine recovery (AR FY2024, released Mar 2025) | Fluorochemical, semiconductor, solar and battery-material producers; Australia has imported 100% of AHF since 1995 (ASX 2 Jul 2026) | Continuous pilot under construction at Bell Bay | Indicative opex US$1,000–1,600/t (lowest cost quartile) and 30–60% operating margin, per company (ASX 2 Jul 2026) |
| Aluminium fluoride (AlF3) | HF combined with aluminium hydroxide using an existing commercial process | Essential smelting chemical; Australian smelters import 100%, typically more than 80% from China | Australian and overseas aluminium smelters | Planned for a commercial plant at Bell Bay | — |
| Metal sulfate co-products | Sulfates from the bath reaction | Could be sold as one chemical or refined into several; options under assessment | Industrial chemical buyers | Under assessment | — |
| Bath recycling service (implicit) | Outlet for smelter surplus bath that would otherwise be stored or landfilled | Global bath market expected to be in growing surplus | Global aluminium majors | Conceptual | — |
Bauxite pillar
| Project | Product | Resource | Logistics | Status |
|---|---|---|---|---|
| Sunrise (Binjour, Qld) – ABX3, 30% | Gibbsite-type metallurgical DSO bauxite | 37.0 Mt (14.2 Mt inferred, 22.8 Mt indicated) | Export via Bundaberg port | Stage 1 (A$2.7M GII) funds mine planning and environmental/port approvals for at least 800,000 t DSO; Stage 1 completion expected 2027 |
| DL130 (Tas) – 100% | Cement-grade bauxite | Not restated in AR FY2025 | Road to port; ABCL Birkenhead, SA | ML 2142P/M granted to 2045; quarrying awaits resolution of TASCAT planning appeal (mediation continuing) |
| Taralga (NSW) – 100% | Gibbsite-type metallurgical bauxite | 37.9 Mt (17.5 inferred, 20.4 indicated) | About 200 km to Port Kembla | GII option lapsed 17 Aug 2026; GII due-diligence study (environmental approvals, transport, port) completed |
| Penrose (NSW) – 100% | Refractory-grade bauxite | No JORC resource | About 90 km to Port Kembla, beside Hume Highway | Discovery stage |
Financial Narrative
All figures are A$'000, fiscal years ending 31 December. FY2021–FY2025 earnings come from the five-year summary in AR FY2025 (Remuneration Report, "Additional information"). FY2021–FY2023 cash flow figures come from aggregator data (Kalkine/TradingView). FY2024–FY2025 figures were verified against AR FY2025.
Income statement — 5-year
Source notes: FY2021–FY2023 revenue from TipRanks (aggregator). FY2024 matches AR FY2025 Note 6. Total income and losses are from the AR FY2025 five-year table.
Derived profitability metrics (analyst calculation)
EPS for FY2021–FY2023 is not publicly disclosed in the documents retrieved. Market Index shows trailing EPS of −A$0.024 and book value per share of A$0.028.
Margins. Gross, operating, EBITDA and net margins are not meaningful. Revenue (A$115k) is a tiny fraction of the cost base. The FY2025 net loss was about 56 times revenue.
Revenue CAGR FY2021–FY2025. Arithmetically 29.4% (A$41k to A$115k), but not meaningful as an indicator of business growth.
Commentary. The jump in the FY2025 loss (A$6.47M vs A$2.03M) is mostly non-cash:
-
A$3.873M accounting loss on deconsolidating ABX3. Sunrise bauxite capitalised exploration was derecognised and the retained 30% was booked at a fair value of A$1.157M.
-
A$1.130M impairment of exploration assets.
Excluding these items, the underlying cash-type loss widened only modestly. Administrative, development and exploration expenses rose 6%, with R&D spend up 14% to A$1.052M and corporate/admin up 23% to A$1.520M. Staff costs fell from A$730k to A$454k, probably reflecting capitalisation to ALCORE and exploration. New finance costs (A$294k) relate to the convertible notes. Grant and R&D income stayed a material offset (A$1.8M). Its composition shifted toward MMI grant drawdown, which has now ended because the unspent MMI funds were repaid.
Balance sheet (AR FY2025)
Commentary. Year-end FY2025 liquidity looked better than at any point since FY2021, after A$8.1M of share placements and A$1.475M of convertible notes. Receivables include a A$1.416M advance for pilot plant equipment.
Capitalised exploration fell A$4.46M, driven by the ABX3 deconsolidation and impairment. Equity rose only A$1.5M despite about A$9.6M of gross capital raised, a sign of heavy loss absorption.
The convertible notes (face value A$1 each) mature on 31 December 2026 and are classified as current. They are a near-term refinancing or conversion item.
Non-current "other liabilities" of A$1.988M are unchanged year-on-year. The extracted note detail was truncated, so their nature is not described here.
Cash flow
FY2021–FY2023 are aggregator data. FY2025 free cash flow is calculated as operating cash flow less A$1,793k of exploration payments.
Ratios (analyst calculation from AR FY2025)
Burn and runway. FY2025 combined operating and investing cash outflow was A$5.98M (going-concern note). Year-end cash was A$3.9M, with a further A$0.92M raised in March 2026. The auditor-acknowledged material uncertainty therefore reflects roughly 9–12 months of runway at the time of signing, before the A$4.1M September 2026 raise and about A$0.6M of FY2025 R&D refunds received in September 2026.
Unlock Company Financials
Unlock this company profile to view its financial data.
View Subscription PlansFinancial Detail
Economic Unit Details
| Economic unit | Legal vehicle | ABx interest | Contents |
|---|---|---|---|
Rare earths | ABX4 Pty Ltd | 100% | Deep Leads–Rubble Mound, Wind Break, T8, T30 and other ELs in northern Tasmania |
Fluorine chemicals | ALCORE Limited | 83% | ALCORE process IP, Bell Bay ATC lease, continuous pilot plant |
Bauxite – Tasmania | ABX4 Pty Ltd | 100% | DL130 project (ML 2142P/M), cement-grade supply to Adelaide Brighton Cement |
Bauxite – Queensland | ABX3 Pty Ltd | 30% (associate) | Sunrise project: Binjour 37.0 Mt; Bundaberg port DSO program |
Bauxite – NSW | ABX2 Pty Ltd | 100% | Taralga (37.9 Mt) and Penrose refractory-grade discovery |
Income line (AUD K)
| Income line (AUD K) | FY2024 | FY2025 |
|---|---|---|
Sale of mineral (bauxite) | 58 | 115 |
R&D tax incentives | 911 | 824 |
MMI grant income (ALCORE) | 551 | 987 |
Other grants | 102 | 7 |
Other income (payable write-back) | 849 | 0 |
Interest income | 167 | 55 |
Total income | 2,638 | 1,988 |
Income Statement
| Metric (AUD K) | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
Revenue – sale of mineral | 41 | 56 | 222 | 58 | 115 |
Total income (revenue + other income + interest) | 556 | 1,800 | 1,685 | 2,638 | 1,988 |
Loss before income tax | -5,868 | -3,573 | -1,799 | -2,029 | -6,467 |
Income tax expense | 0 | 0 | 0 | 0 | 0 |
Loss after income tax | -5,868 | -3,573 | -1,799 | -2,029 | -6,467 |
Income Statement (FY2024–FY2025)
| Line item (AUD K) | FY2024 | FY2025 |
|---|---|---|
Revenue | 58 | 115 |
Interest income | 167 | 55 |
Other income | 2,413 | 1,818 |
Administrative, development and exploration expenses | -2,884 | -3,058 |
Depreciation and amortisation | -83 | -43 |
Impairment of exploration assets | -1,700 | -1,130 |
Loss on loss of control of subsidiary (ABX3) | 0 | -3,873 |
Share of loss of associate | 0 | -10 |
Fair value change in derivative liability | 0 | -47 |
Finance costs | 0 | -294 |
Loss before tax | -2,029 | -6,467 |
Loss attributable to owners of ABX Group | -2,002 | -6,471 |
Loss attributable to non-controlling interest | -27 | 4 |
Income Statement (2)
| Metric (AUD K) | FY2024 | FY2025 |
|---|---|---|
Gross profit (no cost of sales disclosed; equals revenue) | 58 | 115 |
Operating loss (loss before tax + finance costs − interest income) | -2,196 | -6,228 |
EBITDA (operating loss + D&A; impairment and deconsolidation loss included) | -2,113 | -6,185 |
EBITDA excluding impairment and ABX3 deconsolidation loss | -413 | -1,182 |
Net loss attributable to owners | -2,002 | -6,471 |
Per-share (A$ cents)
| Per-share (A$ cents) | FY2024 | FY2025 |
|---|---|---|
EPS basic | -0.80 | -2.40 |
EPS diluted | -0.80 | -2.40 |
Dividends per share | 0 | 0 |
Balance Sheet
| Metric (AUD K) | FY2024 | FY2025 |
|---|---|---|
Cash and cash equivalents | 561 | 3,906 |
Restricted cash (MMI grant trust) | 2,974 | 2,650 |
Trade and other receivables | 184 | 1,857 |
Total current assets | 3,992 | 8,479 |
Mining tenements (capitalised E&E) | 15,455 | 10,997 |
Investment in associate (ABX3) | 0 | 1,147 |
Total assets | 19,536 | 20,656 |
Contract liabilities (grant funds received in advance) | 4,974 | 2,720 |
Borrowings (convertible notes, current) | 370 | 1,833 |
Long-term debt | 0 | 0 |
Total current liabilities | 6,201 | 5,831 |
Total liabilities | 8,311 | 7,934 |
Total equity | 11,225 | 12,722 |
Goodwill and intangibles (excl. E&E) | 0 | 0 |
Working capital (current assets − current liabilities) | -2,209 | 2,648 |
Net debt (borrowings − cash; negative = net cash) | -191 | -2,073 |
Key Financials
| Metric (AUD K) | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
Cash incl. restricted (aggregator) | 6,090 | 2,060 | 1,990 | 720 | 6,560 |
Cash Flow
| Metric (AUD K) | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
Operating cash flow | -2,816 | -4,882 | 5,040 | -668 | -2,115 |
Financing cash flow | 7,590 | 0 | 1,310 | 892 | 9,327 |
Free cash flow (aggregator definition) | -2,907 | -4,986 | 2,540 | -2,608 | -3,908 |
FY2025 cash flow detail (AR FY2025)
| FY2025 cash flow detail (AR FY2025) | FY2024 | FY2025 |
|---|---|---|
Payments to suppliers and employees | -2,500 | -4,104 |
R&D tax incentives received | 911 | 824 |
Grant income received | 653 | 994 |
Payments for exploration and evaluation (capex proxy) | -1,940 | -1,793 |
Restricted cash movement (AR FY2025)
| Restricted cash movement (AR FY2025) | 2000 | -2000 |
|---|---|---|
Proceeds from share issues | 616 | 8,125 |
Proceeds from convertible notes | 370 | 1,475 |
Share issue costs | -94 | -573 |
Dividends paid | 0 | 0 |
Buybacks | 0 | 0 |
Returns & Leverage Ratios (%) and Financial Ratios (x)
| Ratio | FY2024 | FY2025 |
|---|---|---|
ROE (%; loss ÷ average equity) | -16.9 | -54.0 |
ROA (%; loss ÷ average assets) | — | -32.2 |
ROIC | Not meaningful (pre-revenue) | Not meaningful |
Current ratio (x) | 0.64 | 1.45 |
Debt / equity (x) | 0.03 | 0.14 |
Net debt / EBITDA | Not meaningful (net cash, negative EBITDA) | Not meaningful |
Interest coverage | Not applicable | Negative / not meaningful |
Asset turnover (x; revenue ÷ average assets) | about 0.003 | about 0.006 |
Region revenue (AUD K)
| Region revenue (AUD K) | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
Australia | 41 | 56 | 222 | 58 | 115 |
Rest of world | 0 | 0 | 0 | 0 | 0 |
Share Price
| Metric | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
Share price at 30 June (AUD) | 0.098 | 0.14 | 0.098 | 0.047 | 0.036 |
Share Price & Returns
| Date | Market cap (AUD Mn) | Source |
|---|---|---|
Jun 2025 | 10.04 | TipRanks |
Sep 2025 | 19.39 | TipRanks |
1 Sep 2026 | 14.25 | Discovery Alert |
17 Sep 2026 | 14.62 | Discovery Alert |
Valuation Snapshot
| Multiple | Value | Comment |
|---|---|---|
EV/Sales | About 90–110x | EV of about A$12–13M (market cap A$14.3M less about A$2M net cash at FY2025) ÷ A$115k revenue; not meaningful |
P/B | About 1.1–1.2x | Market cap ÷ FY2025 equity of A$12.7M; ex-post dilution will change this |
Capital Markets
| Item | Detail |
|---|---|
Analyst consensus | None. ABX is not covered by a major broker (Market Index). The company website links to "Analyst Coverage" (sponsored research is possible) |
Dividend history and policy | No dividends ever paid; none expected |
Credit ratings | None (Moody's, S&P and Fitch do not rate the company) |
Debt maturity profile | Convertible notes (face value A$1.00 each) due 31 Dec 2026; FY2025 carrying value A$1.833M. No bank debt |
Recent equity raises | A$3.0M at A$0.064 (Sep 2025); A$6.05M at A$0.081 (Nov 2025 / Mar 2026); A$4.1M at A$0.031 (Sep–Oct 2026; 1-for-2 options at A$0.046, 3 years) |
Options overhang | 79.7M options at the AR date (A$0.0576–A$0.1692), plus about 34M placement options and SPP/underwriter options pending EGM approval (29 Oct 2026) |
Analyst Conclusions
Management guidance
ALCORE: pilot installation from early Q4 2026 to Q1 2027, then cold commissioning (ASX 13 Jul 2026). The IGP grant outcome is expected before end-2026.
Deep Leads: economic and scoping studies, infill drilling, and progressing offtake. No study date has been guided.
Sunrise: Stage 1 approvals completion expected in 2027.
DL130: quarrying awaits the TASCAT mediation outcome.
Financial guidance: none.
Consensus
Not available; there is no broker coverage.
Bull case
-
Heavy rare earth scarcity premium. With Dy+Tb at 4.3% of TREO, an MREC carrying 4.0% Dy and 0.7% Tb, and ex-China prices more than 3x Chinese domestic levels, Deep Leads could command a basket price far above typical clay MRECs. A binding offtake or strategic equity investment (Ucore or others) could re-rate a roughly A$15M market cap sharply.
-
ALCORE as a sovereign-capability play. Australia has imported 100% of its anhydrous HF since 1995. A bottom-quartile cost claim, Rio Tinto co-location and possible IGP funding together create a credible path to a first-of-a-kind plant. Successful continuous operation would validate a licensable process for global smelters with surplus bath.
-
Non-dilutive and partner-funded value. GII funds Sunrise (30% free-carried to Stage 2). R&D offsets, grants and the A$300k option fee cut cash burn. Taralga returned at 100% keeps further bauxite optionality.
Bear case
-
Funding treadmill. The FY2025 going-concern uncertainty, a raise at A$0.031 (less than half the A$0.064–0.081 prices of 2025), 80M+ options outstanding and convertible notes due 31 Dec 2026 all point to continued heavy dilution before any revenue.
-
Execution slippage. ALCORE commissioning has moved about three quarters in eight months. Deep Leads has no published economics despite four years since discovery. Low absolute TREO grades leave project economics unproven.
-
Thin governance and partner fragility. A three-person, executive-dominated board with no committees, the lapse of GII's NSW option, the unresolved DL130 appeal and pending EL renewals all add non-technical risk.
Catalysts and monitorables (next 12 months)
| Timing | Catalyst |
|---|---|
| 23 Oct 2026 | SPP close (underwritten) |
| 29 Oct 2026 | EGM approving options and SPP securities |
| 30 Oct 2026 | September quarter Appendix 5B: cash runway |
| Q4 2026 | IGP grant decision (A$3.03M–A$5M) |
| Q4 2026 | Tasmanian EL renewals (Conara, Deloraine, Prossers Road) |
| Q4 2026–Q1 2027 | ALCORE pilot installation and cold commissioning; first HF samples to customers |
| 31 Dec 2026 | Convertible note maturity: conversion versus cash repayment |
| Mar 2027 | FY2026 Annual Report: going-concern language |
| 2026–2027 | Deep Leads scoping study; binding offtake or MOU conversion (Ucore, Rare Earth Technologies) |
| 2,027 | Sunrise approvals; GII Stage 2 (A$2.7M to 75%) |
| Ongoing | DL130 TASCAT mediation outcome; first ABCL cement-grade shipments |
Concluding analyst verdict
ABx Group is a high-risk, binary, early-stage critical-materials option. Its technical credentials outpace its financial capacity.
Over the past 18 months the company has done much of what a junior must to be taken seriously. It expanded the Deep Leads resource to 89 Mt. It produced two MRECs whose dysprosium and terbium content stands out among Australian peers. It cleared a radioactivity hurdle that hampers many rare earth projects. It obtained supportive early customer feedback. In ALCORE it has a genuinely differentiated circular-economy chemical process, sited beside a Rio Tinto smelter, aimed at a market where Australia is fully import-dependent.
Against this, the financial picture is stark:
-
Revenue is immaterial (A$115k in FY2025).
-
The FY2025 loss of A$6.5M was inflated by non-cash items but sits on a real cash burn of about A$6M a year (operating plus investing).
-
The auditor flagged material going-concern uncertainty.
-
The equity has been repriced sharply. The September 2026 raise at A$0.031 implies the market is unconvinced that technical progress has removed financing risk.
-
ALCORE timelines have slipped repeatedly.
-
The bauxite pillar, once the core business, is now partly owned by a partner, with GII declining to extend into NSW.
The investment case rests on two near-term proofs. First, continuous operation of the ALCORE pilot producing on-spec HF in H1 2027. Second, conversion of rare earth customer interest into a binding offtake or strategic equity, which would anchor a scoping study.
Success on either could re-rate a company valued at about A$15M, especially given geopolitical tailwinds in heavy rare earths and the existence of non-dilutive funding channels. Failure or further delay would most likely mean continued sub-scale placements and option-driven dilution.
On balance, ABX suits only speculative, risk-tolerant capital that understands micro-cap funding dynamics. Monitoring should focus on the quarterly Appendix 5B cash balance, the IGP decision, the convertible note settlement and ALCORE commissioning dates as the clearest indicators of whether the strategy is converging toward commercial value.
Unlock Company Financials
Unlock this company profile to view its financial data.
View Subscription PlansExecutive Leadership
Executive Leadership Team
| Name | Title | Tenure | Background | Education |
|---|---|---|---|---|
Joycelyn Morton | Non-Executive Chair | Director since 3 Apr 2024; Chair since 30 Sep 2024 | Senior roles at Shell Australia, Shell International and Woolworths; former CPA Australia National President; former NED of ASC Pty Ltd, Snowy Hydro and Argo Investments; chairs audit/risk committees including at Infrastructure NSW. Current boards: Gelion Plc (AIM), Felix Group Holdings (ASX: FLX), SEC Victoria | FCPA (Fellow and Life Member) |
Dr Mark Cooksey | Managing Director and CEO | Since 1 Feb 2022 | 25+ years in process development at Rio Tinto/Comalco (Gladstone and NZ smelters), GE and CSIRO (about 16 years, including Senior Principal Research Leader) | PhD Chemical & Materials Engineering (Auckland); BE Materials (First Class Hons) and BSc (UWA) |
Ian Levy | Executive Director (exploration; services via Justevian Pty Ltd) | Long-serving director, formerly MD; current service agreement since 1 Feb 2022 | 40+ years in mine development; WMC, Pancontinental, Gympie Gold; ex-CEO Allegiance Mining; 11 years on JORC (4 as Vice-Chair); former Federal President, Australian Institute of Geoscientists | Geologist |
Mathew Watkins | Company Secretary | — | Chartered Accountant, Vistra Australia | CA |
“—” = not publicly disclosed.
Directors' Remuneration
| Name | Salary/fees | Super | Long service leave | Share-based | Total FY2025 | Total FY2024 |
|---|---|---|---|---|---|---|
Joycelyn Morton | 123,583 | 9,400 | 0 | 8,102 | 141,085 | 84,213 |
Dr Mark Cooksey | 280,000 | 32,900 | 5,614 | 12,490 | 331,004 | 323,850 |
Ian Levy | 214,643 | 5,357 | 0 | 6,245 | 226,245 | 223,132 |
Total KMP | 618,226 | 47,657 | 5,614 | 26,837 | 698,334 | 731,221 |
Board & Management Changes
| Date | Change |
|---|---|
1 Feb 2022 | Mark Cooksey appointed MD and CEO |
2 Apr 2024 | Kenneth Boundy resigns as NED |
3 Apr 2024 | Joycelyn Morton appointed NED |
30 Sep 2024 | Paul Lennon resigns as Chair; Morton becomes Chair |
| 2025 | ALCORE appoints a Site Operations Manager |
Q1 2026 | Two Senior Process Engineers hired at ALCORE |
Major Shareholders
| Rank | Holder | Shares | % |
|---|---|---|---|
| 1 | BNP Paribas Nominees <IB Au Noms Retailclient> | 18,072,106 | 4.83 |
| 2 | Citicorp Nominees | 13,084,849 | 3.50 |
| 3 | Mr P & Mrs C Palan <Napla Provident Fund> | 9,505,000 | 2.54 |
| 4 | Aftron Pty Ltd <C E Vrisakis Family> | 7,350,000 | 1.96 |
| 5 | Justevian Pty Ltd <Super Fund> (Ian Levy related) | 7,216,850 | 1.93 |
| 6 | Yarraandoo Pty Ltd <Super Fund> | 7,192,500 | 1.92 |
| 7 | BNP Paribas Noms Pty Ltd | 6,535,238 | 1.75 |
| 8 | Whale Watch Holdings Ltd | 6,000,000 | 1.60 |
| 9 | J P Morgan Nominees Australia | 5,847,309 | 1.56 |
| 10 | Mr Louis Ghirardello | 4,353,421 | 1.16 |
Competitive Landscape
Key Competitors
| Competitor | Listing | Asset / positioning vs ABx |
|---|---|---|
Lynas Rare Earths | ASX: LYC | Only scaled non-China producer of separated rare earths; a potential MREC customer rather than a direct rival |
Iluka Resources | ASX: ILU | Eneabba refinery under construction; heavy rare earth separation; potential customer |
Arafura Rare Earths | ASX: ARU | Nolans hard-rock NdPr project; light rare earth focus |
Ionic Rare Earths | ASX: IXR | Ionic clay project in Uganda (Makuutu) plus recycling in Belfast; closest model peer |
Australian Rare Earths | ASX: AR3 | Koppamurra ionic clay project (SA/Vic); Australian ionic-clay peer |
Meteoric Resources | ASX: MEI | Caldeira ionic clay project (Brazil); larger resource, lower Dy/Tb share |
Brazilian Rare Earths | ASX: BRE | Rocha da Rocha, high-grade Brazilian rare earths |
Victory Metals | ASX: VTM | North Stanmore clay heavy rare earths (WA) |
Aclara Resources | TSX: ARA | Ionic clay heavy rare earth projects in Chile and Brazil; separation in the US |
Serra Verde | Private | Producing ionic clay rare earths in Brazil |
Chinese and Myanmar ionic clay producers | Various | Dominant global source of heavy rare earths |
Key Competitors — Orbia (Koura) – Mexico
| Competitor | Positioning |
|---|---|
Orbia (Koura) – Mexico | Integrated fluorspar-to-HF/AlF3 producer |
Do-Fluoride New Materials – China | Major AlF3 and HF supplier |
Fluorsid – Italy | AlF3 for smelters |
Gulf Fluor – UAE | HF/AlF3 serving Gulf smelters |
Chinese fluorspar-based AlF3 exporters | Supply more than 80% of Australian AlF3 imports (AR FY2025) |
Peer Comparison FY2025
| Metric | ABx Group FY2025 | Australian Rare Earths (AR3) | Ionic Rare Earths (IXR) | Meteoric Resources (MEI) |
|---|---|---|---|---|
Revenue (AUD K) | 115 | — | — | — |
Revenue growth (%) | 98 | — | — | — |
Stage | Resource plus MREC produced | Resource / metallurgy | Resource plus recycling demo | Resource / PFS-stage |
Recent Developments
At the time of retrieval (October 2026), Market Index displayed a "halted/suspended" flag on the ABX page. No corresponding announcement was located in this research pass, so the current trading status should be verified directly on the ASX.



